Comparative effectiveness of combined therapy inhibiting EGFR and VEGF pathways in patients with advanced non-small-cell lung cancer: a meta-analysis of 16 phase II/III randomized trials
about
Comparative effectiveness of combined therapy inhibiting EGFR and VEGF pathways in patients with advanced non-small-cell lung cancer: a meta-analysis of 16 phase II/III randomized trials
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparative effectiveness of c ...... phase II/III randomized trials
@en
Comparative effectiveness of c ...... hase II/III randomized trials.
@nl
type
label
Comparative effectiveness of c ...... phase II/III randomized trials
@en
Comparative effectiveness of c ...... hase II/III randomized trials.
@nl
prefLabel
Comparative effectiveness of c ...... phase II/III randomized trials
@en
Comparative effectiveness of c ...... hase II/III randomized trials.
@nl
P2093
P2860
P356
P1433
P1476
Comparative effectiveness of c ...... phase II/III randomized trials
@en
P2093
Guangyue Yan
Huixian Wang
Shangli Cai
Sijin Cheng
Tongwei Wu
Xiaolong Qi
P2860
P304
P356
10.18632/ONCOTARGET.12294
P407
P577
2016-09-27T00:00:00Z